Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: Golimumab

Early biologic therapy induces larger effect than delayed treatment in Crohn’s disease

Presented By
Prof. Shomron Ben-Horin, Tel-Aviv University, Israel
Conference
ECCO 2022

12 April, 2022 17:21

Upadacitinib appears to be an efficacious therapy for moderately-to-severely ulcerative colitis

Presented By
Prof. Remo Panaccione , University of Calgary, Canada
Conference
ECCO 2022

12 April, 2022 16:44

Guselkumab plus golimumab promising combination for ulcerative colitis

Presented By
Prof. Bruce Sands, Mount Sinai School of Medicine, NY, USA
Trial
Phase 2, VEGA
Conference
ECCO 2022

12 April, 2022 16:10

Risk of hospitalisation and surgery linked to IBD biological

Presented By
Dr Camilla Bjørn Jensen, Frederiksberg Hospital
Conference
ECCO 2021

2 July, 2021 20:20

Vedolizumab and anti-TNF therapies: a real-world comparison

Presented By
Dr G. Mantzaris , Evangelismos Hospital, Greece
Trial
EVOLVE
Conference
ECCO 2020

14 April, 2020 15:35

Vedolizumab, adalimumab, and golimumab compared

Presented By
Dr F.S. Macaluso & Dr A. Casanotti
Conference
ECCO 2020

14 April, 2020 15:32
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy